Lava Medtech Acquisition Common Stock

Lava Medtech Acquisition (LVAC) currently reports a common stock of $120M as of December 2022. That compares with $240K in the prior-year period — up 49828.8% year over year. Use the charts on this page to explore Lava Medtech Acquisition's common stock history and peer comparisons.

Lava Medtech Acquisition's common stock increased from $240K to $120M — a 49828.8% year-over-year increase (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lava Medtech Acquisition reported $120M in common stock as of December 2022. That compares with $240K in the prior-year period — up 49828.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $120M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lava Medtech Acquisition, and consider following LVAC for alerts when major investors trade the stock.